Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Evaluate after-tax yields across bond options in retirement to determine which bond yields the most income after taxes.
26,078 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Occidental Petroleum surges in 2026 on debt cleanup after the OxyChem sale, with oil prices supportive but questions ...
A veteran Wall Street observer reveals a clean, repeatable way to find the next big chip stock winners. Read how to s...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...
A former hedge fund executive assistant goes public with a memoir detailing the grind behind elite money management. ...
When a global intelligence stock sinking trend hits the market, it signals shifts in growth expectations and margins....
Bitcoin trades around $78,000 as PI token declines for a second straight weekend, fading hopes for a rebound. Analyst...
Ethereum stabilizes around $2,100 as real-world asset tokenization accelerates, driving ETH-led growth in the RWA sec...
Bitcoin price crashes below a key level as investors weigh a hypothetical Fed Chair transition, triggering a wave of ...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
London expands sanctions to 18 crypto platforms linked to Russia’s war-financing network, freezing assets and signali...
A 15-year view of Alphabet shows how a modest initial bet could compound amid AI and cloud expansion, delivering a po...